Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T16:44:20.881Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:44:20.881Z.

Quote observation: 2026-10-06T15:40:39.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -24,441,000
Quote market capitalization: 11,543,686
Total debt · period ending 2026-06-30: 34,914,000
Cash · period ending 2026-06-30: 3,529,000

FMP input reference: e7a98ef6549bf85b46c4ba181efc1584300b0c5a2a31302d891700dc780dc00a

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

PLUR EBITDA Yield Metrics

EBITDA YIELD

N/A

EBITDA YIELD AVG TTM

N/A

EBITDA YIELD AVG 3Y

N/A

EBITDA YIELD AVG 5Y

N/A

EBITDA YIELD AVG 10Y

N/A

EBITDA YIELD AVG 15Y

N/A

EBITDA YIELD AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

PLUR Competitors' EBITDA Yield

PLUR

Pluri Inc.

Current

Market Cap

$11.54M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PHIO

Phio Pharmaceuticals Corp.

vs PLUR

Market Cap

$11.61M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BFRI

Biofrontera Inc.

vs PLUR

Market Cap

$11.44M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADIL

Adial Pharmaceuticals, Inc.

vs PLUR

Market Cap

$11.19M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KPRX

Kiora Pharmaceuticals, Inc.

vs PLUR

Market Cap

$11.17M

EBITDA Yield

N/A

TTM Avg

41.52%

3Y Avg

41.52%

5Y Avg

41.52%

BIVI

BioVie Inc.

vs PLUR

Market Cap

$11.12M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNSY

Cerenome, Inc.

vs PLUR

Market Cap

$11.08M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IRIX

IRIDEX Corporation

vs PLUR

Market Cap

$12.28M

EBITDA Yield

N/A

TTM Avg

0.96%

3Y Avg

2.71%

5Y Avg

3.80%

CABR

Caring Brands, Inc.

vs PLUR

Market Cap

$10.73M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLRZ

Polyrizon Ltd.

vs PLUR

Market Cap

$10.68M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Pluri Inc. (PLUR)	$11.54M	N/A	N/A	N/A	N/A
Phio Pharmaceuticals Corp. (PHIO)vs ›	$11.61M	N/A	N/A	N/A	N/A
Biofrontera Inc. (BFRI)vs ›	$11.44M	N/A	N/A	N/A	N/A
Adial Pharmaceuticals, Inc. (ADIL)vs ›	$11.19M	N/A	N/A	N/A	N/A
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.17M	N/A	41.52%	41.52%	41.52%
BioVie Inc. (BIVI)vs ›	$11.12M	N/A	N/A	N/A	N/A
Cerenome, Inc. (CNSY)vs ›	$11.08M	N/A	N/A	N/A	N/A
IRIDEX Corporation (IRIX)vs ›	$12.28M	N/A	0.96%	2.71%	3.80%
Caring Brands, Inc. (CABR)vs ›	$10.73M	N/A	N/A	N/A	N/A
Polyrizon Ltd. (PLRZ)vs ›	$10.68M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PLUR EBITDA Yield History

DATE	EBITDA YIELD
2003-11-19	0.10%
2003-11-18	0.10%
2003-11-17	0.09%
2003-11-14	0.10%
2003-11-13	0.09%
2003-11-12	0.10%
2003-11-11	0.10%
2003-11-10	0.10%
2003-11-07	0.10%
2003-11-06	0.09%
2003-11-05	0.09%
2003-11-04	0.09%
2003-11-03	0.10%
2003-10-31	0.09%
2003-10-30	0.10%
2003-10-29	0.10%
2003-10-28	0.09%
2003-10-27	0.09%
2003-10-24	0.08%
2003-10-23	0.08%
2003-10-22	0.09%
2003-10-21	0.09%
2003-10-20	0.09%
2003-10-17	0.09%
2003-10-16	0.08%
2003-10-15	0.09%

EBITDA Yield: N/A

PLUR EBITDA Yield Chart

PLUR EBITDA Yield Metrics

PLUR Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

PLUR EBITDA Yield History

Related Metrics